BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 6875864)

  • 1. Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats.
    Allen TM; Everest JM
    J Pharmacol Exp Ther; 1983 Aug; 226(2):539-44. PubMed ID: 6875864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of drug release from liposomal formulations in ocular fluid.
    Jafari MR; Jones AB; Hikal AH; Williamson JS; Wyandt CM
    Drug Deliv; 1998; 5(4):227-38. PubMed ID: 19569989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution.
    Allen TM; Murray L; MacKeigan S; Shah M
    J Pharmacol Exp Ther; 1984 Apr; 229(1):267-75. PubMed ID: 6707942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation.
    Beaumier PL; Hwang KJ; Slattery JT
    Res Commun Chem Pathol Pharmacol; 1983 Feb; 39(2):277-89. PubMed ID: 6844745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model.
    Storm G; Roerdink FH; Steerenberg PA; de Jong WH; Crommelin DJ
    Cancer Res; 1987 Jul; 47(13):3366-72. PubMed ID: 3581073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of phospholipid interactions between high-density lipoproteins and small unilamellar vesicles.
    Allen TM
    Biochim Biophys Acta; 1981 Jan; 640(2):385-97. PubMed ID: 7213898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of bovine serum on the phase transition temperature of cholesterol-containing liposomes.
    Gaber MH
    J Microencapsul; 1998; 15(2):207-14. PubMed ID: 9532526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits.
    Cabanes A; Reig F; Antón JM; Arboix M
    Am J Vet Res; 1995 Nov; 56(11):1498-501. PubMed ID: 8585663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of liposomes with human erythrocyte ghosts.
    Greidziak M; Ehrke R; Baust G; Torchilin VP; Lasch J
    Biomed Biochim Acta; 1990; 49(4):189-200. PubMed ID: 2403338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of size and lipid composition on the pharmacokinetics of intravitreal liposomes.
    Barza M; Stuart M; Szoka F
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):893-900. PubMed ID: 3106257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Release profile of compound liposomes entrapped with vincristine sulfate and mitoxantrone chlorhydric acid in vitro and their distribution in mice].
    Chen T; Hou SX; Wang YY; Zhang WS; Chen DH
    Yao Xue Xue Bao; 2006 Dec; 41(12):1170-5. PubMed ID: 17290615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of liposome structure and lipid composition on the activation of the tumoricidal properties of macrophages by liposomes containing muramyl dipeptide.
    Schroit AJ; Fidler IJ
    Cancer Res; 1982 Jan; 42(1):161-7. PubMed ID: 7053846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and organ distribution of liposome-encapsulated L-carnitine in rats.
    Jäger W; Koch HP
    Arzneimittelforschung; 1993 Sep; 43(9):974-7. PubMed ID: 8240461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of liposome encapsulated cisplatin in rats.
    Freise J; Mueller WH; Magerstedt P; Schmoll HJ
    Arch Int Pharmacodyn Ther; 1982 Aug; 258(2):180-92. PubMed ID: 6890331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic distribution of small unilamellar liposomes as a function of liposomal lipid composition.
    Spanjer HH; van Galen M; Roerdink FH; Regts J; Scherphof GL
    Biochim Biophys Acta; 1986 Dec; 863(2):224-30. PubMed ID: 3790559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of adriamycin delivery to liver metastatic cells with increased tumoricidal effect using liposomes as drug carriers.
    Gabizon A; Goren D; Fuks Z; Barenholz Y; Dagan A; Meshorer A
    Cancer Res; 1983 Oct; 43(10):4730-5. PubMed ID: 6883331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability and release of topical tranexamic acid liposome formulations.
    Manosroi A; Podjanasoonthon K; Manosroi J
    J Cosmet Sci; 2002; 53(6):375-86. PubMed ID: 12512014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.